日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

STK25 inhibits cancer-associated fibroblast activation to overcome cetuximab resistance in colorectal cancer

STK25抑制癌相关成纤维细胞活化,从而克服结直肠癌中的西妥昔单抗耐药性

Hou, Yifan; Chen, Jiangbo; Hao, Hao; Song, Tongkun; Song, Lin; Xing, Pu; Weng, Kai; Ran, Yumeng; Yang, Xinying; Qiao, Xiaowen; Chen, Jie; Yao, Ruibin; Yang, Hong; Chen, Lei; Di, Jiabo; Xu, Kai; Su, Xiangqian; Jiang, Beihai

STK25 Loss Augments Anti-PD-1 Therapy Efficacy by Regulating PD-L1 Stability in Colorectal Cancer

STK25缺失通过调节PD-L1稳定性增强结直肠癌中抗PD-1疗法的疗效

Qiao, Xiaowen; Xing, Pu; Hao, Hao; Chen, Jiangbo; Song, Lin; Hou, Yifan; Yang, Xinying; Weng, Kai; Chen, Jie; Gao, Pin; Song, Tongkun; Yang, Hong; Liu, Tianqi; Ran, Yumeng; Chen, Bo; Zhao, Wei; Di, Jiabo; Wang, Zaozao; Zhang, Jun; Su, Xiangqian; Jiang, Beihai

Inhibition of GCKIII kinases STK25 and MST3 mitigates organ lipotoxicity and enhances metabolic resilience under nutritional stress

抑制GCKIII激酶STK25和MST3可减轻器官脂毒性,并增强营养应激下的代谢韧性。

Andersson, Emma; Gongye, Xiangdong; Cansby, Emmelie; Zhang, Jingjing; Caputo, Mara; Asiedu, Bernice; Garellick, Viktor; Booten, Sheri; Murray, Sue; Font-Gironès, Ferran; Ruud, Johan; Lind, Dan Emil; Amrutkar, Manoj; Howell, Brian W; Wernstedt Asterholm, Ingrid; Mahlapuu, Margit

Therapeutic Potential of STE20-Type Kinase STK25 Inhibition for the Prevention and Treatment of Metabolically Induced Hepatocellular Carcinoma

STE20型激酶STK25抑制剂在预防和治疗代谢性肝细胞癌中的治疗潜力

Ying Xia ,Mara Caputo ,Emma Andersson ,Bernice Asiedu ,Jingjing Zhang ,Wei Hou ,Manoj Amrutkar ,Emmelie Cansby ,Nadia Gul ,Anne Gemmink ,Caitlyn Myers ,Mariam Aghajan ,Sheri Booten ,Andrew J Hoy ,Anetta Härtlova ,Per Lindahl ,Anders Ståhlberg ,Gert Schaart ,Matthijs K C Hesselink ,Andreas Peter ,Sue Murray ,Margit Mahlapuu

TLR-induced STK25 activation promotes IRF5-mediated inflammation

TLR诱导的STK25激活促进IRF5介导的炎症反应

Matthew R Rice ,Bharati Matta ,Loretta Wang ,Qi Luo ,Jeremy De Guzman ,Dinesh Srinivasan ,Katelyn R Ludwig ,Surya Indukuri ,Leianna Brune ,Seng-Lai Tan ,Betsy J Barnes

AP-2α gene deregulation is associated with renal cell carcinoma patient survival

AP-2α 基因失调与肾细胞癌患者生存相关

Po-Hung Lin #, Chin-Hsuan Hsieh #, Kai-Jie Yu, I-Hung Shao, Cheng-Keng Chuang, Todd Hsu, Wen-Hui Weng, See-Tong Pang

Correction to: Lanthanum Chloride Induces Axon Abnormality Through LKB1-MARK2 and LKB1-STK25-GM130 Signaling Pathways

更正:氯化镧通过 LKB1-MARK2 和 LKB1-STK25-GM130 信号通路诱导轴突异常

Song, Zeli; Mao, Haoyue; Liu, Jinxuan; Sun, Wenchang; Wu, Shengwen; Lu, Xiaobo; Jin, Cuihong; Yang, Jinghua

STK25 inhibits PKA signaling by phosphorylating PRKAR1A

STK25 通过磷酸化 PRKAR1A 来抑制 PKA 信号传导。

Xiaokan Zhang ,Bryan Z Wang ,Michael Kim ,Trevor R Nash ,Bohao Liu ,Jenny Rao ,Roberta Lock ,Manuel Tamargo ,Rajesh Kumar Soni ,John Belov ,Eric Li ,Gordana Vunjak-Novakovic ,Barry Fine

Ste20-like Kinase STK25: A Potential Target in Prevention and Therapy of NASH-Associated Hepatocellular Carcinoma?

Ste20样激酶STK25:NASH相关肝细胞癌预防和治疗的潜在靶点?

Kühnel, Florian

STK25 enhances hepatocellular carcinoma progression through the STRN/AMPK/ACC1 pathway

STK25 通过 STRN/AMPK/ACC1 通路增强肝细胞癌进展

Yichao Zhang #, Junhui Xu #, Zhendong Qiu, Yongjun Guan, XiaoYi Zhang, Xin Zhang, Dongqi Chai, Chen Chen, Qinyong Hu #, Weixing Wang #